Skip to main content

Table 8 Base case results—tiotropium vs glycopyrronium

From: Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden

 

GLY

TIO

TIO–GLY

Costs (SEK 2014)

 Treatment costs

13,965

17,315

3351

 Direct costs

166,308

165,380

−928

 Total costs

180,272

182,695

2423

Health outcomes

 QALYs

7.02

7.25

0.23

 Life years

9.93

10.26

0.33

ICER

10,456

  1. All costs and effects discounted at an annual rate of 3 %
Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us